Considerations for Combination Therapies Aiming Disease Modification in Parkinson’s
A new analysis published in npj Parkinson’s Disease considers how combination therapies might better slow or modify Parkinson’s disease—an approach ...
A new analysis published in npj Parkinson’s Disease considers how combination therapies might better slow or modify Parkinson’s disease—an approach ...
Parkinson's disease (PD) ranks as the second most prevalent neurodegenerative disorder following Alzheimer's disease, impacting more than 10 million individuals ...
A newly identified mutation in the LRRK2 gene, known as P1446L, has been found to drive the degeneration of dopaminergic ...
In a groundbreaking endeavor to unravel the genetic complexities underpinning Alzheimer’s disease, scientists from Baylor College of Medicine and the ...
Nicotinamide adenine dinucleotide (NAD⁺) has emerged at the forefront of cellular metabolism as a fundamental coenzyme driving energy homeostasis and ...
Recent advancements in neuroscience are shedding light on the complex mechanisms behind Alzheimer's disease, particularly the role of tau proteins. ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine